Drug intelligence / Profile preview

fuzhenghefuzhiyang

Development stage: Unknown
Lead developer: Guangzhou Yuekang Biology Pharmacy
Administration: Topical

Overview

Fuzhenghefuzhiyang is a Traditional Chinese Medicine (TCM) granule formulation developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of mild-to-moderate psoriasis vulgaris. The formulation is designed to address the TCM pathological mechanisms of psoriasis by 'Fuzheng' (strengthening the body's vital energy or resistance), 'Hefu' (harmonizing or restoring the skin), and 'Zhiyang' (relieving itching). It is typically administered orally as granules and has been evaluated in clinical trials, often in combination with topical agents like urea, to assess its efficacy in reducing skin lesion severity and improving patient quality of life.

Other names: Fuzhenghefuzhiyang granulesFuzheng Hefu Zhiyang

Beyond the preview

Go deeper on fuzhenghefuzhiyang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuzhenghefuzhiyang.

Explore the full profile